Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul 20;101(29):10602-7.
doi: 10.1073/pnas.0404100101. Epub 2004 Jul 12.

Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C

Tobias N Dechow  1 , Laura Pedranzini, Andrea Leitch, Kenneth Leslie, William L Gerald, Irina Linkov, Jacqueline F Bromberg
Affiliations

Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C

Tobias N Dechow et al. Proc Natl Acad Sci U S A. .

Abstract

Persistently activated Stat3 is found in many different cancers, including approximately 60% of breast tumors. Here, we demonstrate that a constitutively activated Stat3 transforms immortalized human mammary epithelial cells and that this oncogenic event requires the activity of matrix metalloproteinase-9 (MMP-9). By immunohistochemical analysis, we observe a positive correlation between strong MMP-9 expression and tyrosine phosphorylated Stat3 in primary breast cancer specimens. These results demonstrate a relationship between activated Stat3 and MMP-9 in breast oncogenesis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Stat3-C induces tumorigenesis of HMLHT and MCF-10A cells in a dose-dependent manner. (A) Anti-Flag Western blot showing Stat3-C expression in MCF-10A and HMLHT cells expressing pBabe control vector (pB) and pBabe-Stat3-C (pB-3C). (B) EMSA performed with nuclear extracts from cell lines described in A. Stat3-C DNA binding was supershifted with anti-Flag antibody, indicated with a +. (C) Colony formation in soft agar of empty retroviral control (pB) and Stat3-C infected (pB-3C) MCF-10A and HMLHT cells (mean ± SD). (D) Tumor growth in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice when using the HMLHT pBabe control cell line and subclones with high Stat3-C expression levels (no. 16 and no. 24) or low Stat3-C expression (3CL). Results are expressed as the mean of 4–10 tumors ± SD at the indicated times after injection. (E) Nuclear extracts from a Stat3-C-derived tumor (tu), normal murine breast tissue (nbr), and cell line no. 16 (+con) were analyzed for the presence of Stat3-C by Flag immunoblot.
Fig. 2.
Fig. 2.
Stat-3C-dependent induction of MMP-9 mRNA, luciferase activity, and protein. (A) Induction of MMP-9 mRNA in pBabe-Stat3-C (pB-3C)- and pBabe (pB)-infected MCF-10A and HMLHT cells determined by RT-PCR (Upper), normalized to GAPDH (Lower). (B) HMLHT cells were transfected with an MMP-9 promoter luciferase construct in conjunction with either pBabe (pB)- or pB Stat3-C (3-C)-expressing plasmids. Luciferase activities are shown as the mean ± SD of three experiments performed in duplicate. (C) MMP-9 protein expression in cell culture medium from pBabe (pB)- and pBabe-Stat3-C (pB-3C)-infected MCF-10A and HMLHT cells shown by gelatin zymography.
Fig. 3.
Fig. 3.
Active MMP-9 is localized to the cell surface. (A and B) An ELISA specific for enzymatically active MMP-9 was performed on cell culture medium (A) and cell extracts (B) from pBabe (pB)- and pBabe-Stat3-C (pB-3C)-expressing cells. MMP-9 activity from cell culture medium and cell extracts was measured without (black columns) and with pretreatment with APMA (gray columns). Results are shown as the mean ± SD of three experiments performed in duplicate. (C) In situ zymography of HMLHT cells expressing pBabe and pBabe-Stat3-C (pB-3-C) treated with DMSO (Upper) or 1.5 μM MMP-2/9 inhibitor (Lower). The cells were then overlayed with DQ gelatin. Green staining indicates MMP-9-digested gelatin whereas blue indicates nuclear staining [4′,6-diamidino-2-phenylindole (DAPI)]. (D) MMP-9 expression shown by immunofluorescence in the cell lines described in C.
Fig. 4.
Fig. 4.
MMP-9 activity is required for Stat-3C-dependent anchorage-independent growth. (A) Anchorage-independent growth of pBabe-Stat3-C cells (pB-3C)-, pBabe v-src (pB-src)-, and pBabe H-ras V12 (pB-ras)-expressing HMLHT cells. DMSO (D) control and increasing concentrations of MMP-2/9 inhibitor in μM were added to the soft agar assay every other day (mean ± SD). (B) Gelatin zymography of supernatants derived from HMLHT cells expressing either pBabe (pB), pBabe-Stat3-C (3C), pBabe v-src (src), or pBabe H-ras V12 (ras) and 0.5 ng of recombinant MMP-9 as a loading control.
Fig. 5.
Fig. 5.
Persistently phosphorylated Stat3 correlates with MMP-9 expression in primary breast cancer samples. Immunohistochemistry was performed on sequential sections of 34 primary breast cancer microtissue arrays with antiphospho-Stat3 (pStat3) and anti-MMP-9 antibodies. A schematic overview of the tissue arrays and a summary of the immunohistochemistry results are shown. Representative sections of strong staining are indicated as +++ and shaded in black, moderate staining as ++ and shaded in gray, and weak to no staining as 0/+ and shaded in white. Normal breast had 0/+ staining for both pStat3 and MMP-9. A positive correlation was observed between (+++/++) staining for pStat3 and MMP-9 (P < 0.001) by χ2 test.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Darnell, J. E., Jr. (1997) Science 277, 1630–1635. - PubMed
    1. Bromberg, J. (2002) J. Clin. Invest. 109, 1139–1142. - PMC - PubMed
    1. Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., et al. (2001) Oncogene 20, 2499–2513. - PubMed
    1. Bromberg, J., Wrzeszczynska, M., Devgan, G., Zhao, Y., Albanese, C., Pestell, R. & Darnell, J. E. J. (1999) Cell 98, 295–303. - PubMed
    1. Dolled-Filhart, M., Camp, R. L., Kowalski, D. P., Smith, B. L. & Rimm, D. L. (2003) Clin. Cancer Res. 9, 594–600. - PubMed

Publication types

LinkOut - more resources

  NODES
twitter 2